TickerGuard
Buy Day today: Neutral (47) Mixed market breadth · no major macro event
TSHA

Taysha Gene Therapies Inc

Healthcare · Biotechnology · —

4.40$ +0.9% vs. previous close Closing price · As of: Oct 7, 2026

Statements

Balance Sheet

Taysha Gene Therapies Inc (TSHA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 470 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet TSHA
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
196 173 153 200 180 160 138 333 317 343 300 470
172 150 131 178 162 142 121 316 300 325 282 461
164 144 124 173 158 139 117 313 297 320 277 455
164 144 124 173 158 139 117 313 297 320 277 455
245 98 99 92 91 89 83 85 98 96 88 83
180 37 39 34 29 26 23 25 29 27 20 26
1.5 1.6 1.7 1.8 1.8 1.9 1.8 1.7 1.7 – – –
7.5 6.4 10 8.7 4.9 3.6 4.3 7.7 5.4 6.3 4.6 9.2
39 41 41 38 43 44 42 41 51 50 49 49
-49 75 54 109 89 72 55 249 219 247 212 387
-561 -513 -537 -558 -584 -602 -624 -651 -683 -711 -754 -800
126 187 231 233 268 205 269 298 353 320 367 369

Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?